Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland
- PMID: 36771403
- PMCID: PMC9920487
- DOI: 10.3390/nu15030695
Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland
Abstract
Introduction: All epidemiological studies suggest that vitamin D deficiency is prevalent among the Polish general population. Since vitamin D deficiency was shown to be among the risk factors for many diseases and for all-cause mortality, concern about this problem led us to update the previous Polish recommendations. Methods: After reviewing the epidemiological evidence, case-control studies and randomized control trials (RCTs), a Polish multidisciplinary group formulated questions on the recommendations for prophylaxis and treatment of vitamin D deficiency both for the general population and for the risk groups of patients. The scientific evidence of pleiotropic effects of vitamin D as well as the results of panelists' voting were reviewed and discussed. Thirty-four authors representing different areas of expertise prepared position statements. The consensus group, representing eight Polish/international medical societies and eight national specialist consultants, prepared the final Polish recommendations. Results: Based on networking discussions, the ranges of total serum 25-hydroxyvitamin D concentration indicating vitamin D deficiency [<20 ng/mL (<50 nmol/L)], suboptimal status [20-30 ng/mL (50-75 nmol/L)], and optimal concentration [30-50 ng/mL (75-125 nmol/L)] were confirmed. Practical guidelines for cholecalciferol (vitamin D3) as the first choice for prophylaxis and treatment of vitamin D deficiency were developed. Calcifediol dosing as the second choice for preventing and treating vitamin D deficiency was introduced. Conclusions: Improving the vitamin D status of the general population and treatment of risk groups of patients must be again announced as healthcare policy to reduce a risk of spectrum of diseases. This paper offers consensus statements on prophylaxis and treatment strategies for vitamin D deficiency in Poland.
Keywords: 25-hydroxyvitamin-D; calcifediol; cholecalciferol; general population guidelines; risk groups; vitamin D deficiency.
Conflict of interest statement
W.B.G. receives funding from Bio-Tech Pharmacal, Inc. (Fayetteville, AR, USA). The other authors have no conflicts of interest to declare.
References
-
- Chlebna-Sokół D., Konstantynowicz J., Abramowicz P., Kulik-Rechberger B., Niedziela M., Obuchowicz A., Ziora K., Karalus-Gach J., Golec J., Michałus I., et al. Evidence of a significant vitamin D deficiency among 9–13-year-old Polish Karczmarewicz E, Czekuc-Kryskiewicz E, Dobrzanska A. Impact of vitamin D supplementation children: Results of a multicentre study. Eur. J. Nutr. 2019;58:2029–2036. doi: 10.1007/s00394-018-1756-4. - DOI - PMC - PubMed
-
- Czech-Kowalska J., Latka-Grot J., Bulsiewicz D., Jaworski M., Pludowski P., Wygledowska G., Chazan B., Pawlus B., Zochowska A., Borszewska-Kornacka M.K., et al. Impact of Vitamin D Supplementation during Lactation on Vitamin D Status and Body Composition of Mother-Infant Pairs: A MAVID Randomized Controlled Trial during lactation on vitamin D status and body composition of mother-infant pairs: A MAVID randomized controlled trial. PLoS ONE. 2014;9:e107708. doi: 10.1371/journal.pone.0107708. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical